论文部分内容阅读
目的 :讨论运用硫酸镁来治疗小儿哮喘患儿的安全性及有效性。方法 :选取我院2008年4月至2013年8月期间收治的30例哮喘患儿,采用数字单双号的模式随机将其分为对照组与实验组,每组各15例患儿,针对对照组的患儿运用索茶碱来进行治疗,针对实验组的患儿运用硫酸镁来进行治疗,比较两组患儿的临床疗效。结果 :实验组患儿的临床总有效率达到了93.33%,明显高于对照组患儿的86.67%,两组患儿之间的对比差异具有统计学意义(P<0.05);对照组患儿在住院时间与不良反应的发生率方面都显著高于对照组患儿,差异具有可比性(P<0.05)。结论 :运用硫酸镁来治疗哮喘患儿具有住院时间短、不良反应的发生率低以及临床疗效明显等特点,具有非常重要的现实意义。
Objectives: To discuss the safety and efficacy of magnesium sulfate in children with asthma. Methods: Thirty patients with asthma who were admitted to our hospital from April 2008 to August 2013 were randomly divided into control group and experimental group with 15 single children in each group. Control group of children with cocaine for treatment, the experimental group of children treated with magnesium sulfate, the clinical efficacy of two groups were compared. Results: The total effective rate of the experimental group was 93.33%, which was significantly higher than that of the control group (86.67%). The difference between the two groups was statistically significant (P <0.05) There was a significant difference in the length of hospital stay and the incidence of adverse reactions between the control group and the control group (P <0.05). CONCLUSIONS: The use of magnesium sulfate in children with asthma has the characteristics of short hospital stay, low incidence of adverse reactions and obvious clinical efficacy, which is of great practical significance.